Stay updated on Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page revision/version indicator was updated from v3.5.0 to v3.5.2. No study content or key details were changed.
    Difference
    0.0%
    Check dated 2026-04-21T09:28:51.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Napoli, Italy 80100 was replaced with Naples, Italy 80100. The Naples location was added and Napoli removed; page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-23T13:54:53.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-09T01:58:32.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces v3.4.1 as a minor internal update with no user-facing content or functionality changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-15T15:16:29.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Page revision updated to v3.4.1 with new dates (2026-02-04, 2026-01-15, 2026-01) and removal of 2025-12 entries.
    Difference
    0.1%
    Check dated 2026-02-08T11:29:35.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Added: a glossary toggle and metadata fields including 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', plus the Revision: v3.4.0. Removed: the field 'Last Update Submitted that met QC Criteria', 'Last Update Posted (Estimated)', 'No FEAR Act data', and the previous revision 'v3.3.4'.
    Difference
    0.1%
    Check dated 2026-01-25T08:29:59.000Z thumbnail image

Stay in the know with updates to Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page.